Related Experiment Video

Updated: Jul 8, 2026

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
06:16

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

Adenoviral gene therapy in gastric cancer: a review

Nima Khalighinejad1, Hesammodin Hariri, Omid Behnamfar

  • 1Isfahan University of Medical Sciences, Number 111, 5th street, Mardavij Street, Isfahan, Iran. nima_kh8@yahoo.com

World Journal of Gastroenterology
|January 12, 2008
PubMed

Insights

Gene therapy using adenoviral vectors offers a promising new avenue for treating gastric cancer, a leading cause of cancer death. This approach targets cancer cells to induce apoptosis and inhibit metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Gastric cancer is a prevalent malignancy with poor patient prognosis.
  • Current treatments are insufficient, highlighting the need for novel therapeutic strategies.
  • Gastric cancer's molecular basis involves disruptions in cellular regulation.

Purpose of the Study:

  • To review recent advancements in adenoviral vector-based gene therapy for gastric cancer.
  • To explore strategies utilizing gene therapy for cancer treatment.

Main Methods:

  • Review of current literature on adenoviral vectors in cancer gene therapy.
  • Focus on strategies for apoptosis induction, metastasis inhibition, and targeted cancer cell delivery.

Main Results:

  • Adenoviral vectors are effective delivery systems for gene therapy in cancer.
  • Gene therapy can introduce therapeutic genes (suicide, tumor suppressor, anti-angiogenesis) into cancer cells.
  • Strategies include inducing apoptosis, inhibiting metastasis, and targeting cancer cells.

Conclusions:

  • Adenoviral gene therapy presents a viable alternative treatment for gastric cancer.
  • Further research into adenoviral vector applications can improve gastric cancer outcomes.

More Related Videos

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction04:43

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction

Published on: October 11, 2024

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...